Pioneering diagnostics
E.g., 19/12/2014
E.g., 19/12/2014

bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections

18 November, 2014

Marcy l’Etoile, FranceSan Diego, California, United States – November 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an...

BioFire Defense, a bioMérieux company, receives fast-track authorization of FilmArray® Ebola Test

27 October, 2014

Marcy l’Etoile (France) - October 27, 2014 - BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for its commercial FilmArray...

Business Review for the Nine Months Ended September 30, 2014

22 October, 2014

Solid growth in nine-month sales:

  • Up 7.4%, including BioFire and at constant exchange rates
  • Up 3.5% at constant exchange rates and scope of consolidation, in line with the full-year target

The Americas: a...

bioMérieux inaugurates a new multidisciplinary R&D center for infectious disease diagnostics

Marcy l’Etoile, October 10, 2014 – A new bioMérieux R&D center was inaugurated at the company’s La Balme-Les-Grottes site (Isère, southeastern France) by Alain Mérieux, Chairman of Institut Mérieux, Jean-Luc Bélingard, Chairman of bioMérieux, and Alexandre Mérieux, Chief Executive Officer of bioMérieux. Geneviève Fioraso, French Secretary of State for Higher Education and Research, attended the ceremony.

10 October, 2014

The R&D Center at La Balme-Les-Grottes is specialized in the development of new diagnostic solutions in microbiology: high medical value tests for improved patient care and fully automated solutions to reduce time to results and enhance the efficiency of laboratory workflows.

...

bioMérieux launches chromID® Salmonella Elite, the new generation of culture media for earlier detection of Salmonella strains in clinical fecal samples

18 September, 2014

Marcy l'Étoile, France – September 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the launch of chromID® Salmonella Elite, a new selective chromogenic culture medium for the isolation and rapid identification of...

bioMérieux - First-Half 2014 Results

03 September, 2014

Solid growth in first-half sales

  • Up 7.9%, including BioFire and at constant exchange rates
  • Up 4.2% at constant exchange rates and scope of consolidation

2014 financial objectives maintained

...

bioMérieux VIRTUO™, the new generation of blood culture system, is CE-marked

VIRTUO™ is the next dimension of blood culture microbial detection

23 July, 2014

Marcy l'Etoile, France, July 23, 2014 - bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIRTUO™, the new generation of BacT/ALERT®, has been CE-marked. This uniquely innovative automated blood culture microbial...

bioMérieux - Second-Quarter 2014 Business Review

17 July, 2014

  • Solid growth in first-half sales
    • Up 7.9%, including BioFire and at constant exchange rates
    • Up 4.2% like-for-like*, in line with the target for the year
    • Up 3.5% on a reported basis
  • Greater...

The General Shareholders’ Meeting of bioMérieux approves the appointment of two new independent directors

28 May, 2014

Marcy l’Etoile, France, May 28, 2014 - The General Meeting of Shareholders of bioMérieux, a world leader in the field of in vitro diagnostics, today approved the appointment of two new independent directors, Agnès Lemarchand and Philippe Gillet.

Agnès...

BioFire’s FilmArray® Gastrointestinal Panel Receives FDA Clearance

05 May, 2014

Marcy l’Etoile, France - May 5, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its new molecular biology affiliate, received U.S. Food and Drug Administration (FDA) 510(k) clearance for the FilmArray...